Text size A - A+

RSS

FOR RELEASE 8/3/2010, Tuesday

Bausch + Lomb Introduces the Stellaris® PC Vision Enhancement System 

Versatile Device Benefits Both Retinal and Cataract Surgeons 

ALISO VIEJO, Calif. -- Bausch + Lomb, the global eye health company, today announced the worldwide launch of the Stellaris® PC (Procedural Choice) Vision Enhancement System. The new, state-of-the-art, combined vitrectomy and phacoemulsification system allows surgeons to have true "procedural choice" by providing the most advanced technology for both vitreoretinal and cataract surgery in a single system.

The new Stellaris PC provides a high-performance, feature-rich, combined experience that leverages Bausch + Lomb’s history in retinal innovation with the demonstrated excellence of the Stellaris phacoemulsification platform. It is a versatile system that allows surgeons the flexibility to perform different ophthalmic procedures while saving time, space and money for the surgeons and the patients they serve.

Dr. Carl Awh, a long-time adviser to Bausch + Lomb and a private-practice physician with Tennessee Retina in Nashville, said, “The Stellaris PC meets the needs of today’s vitreoretinal and cataract surgeons. It allows us to perform the most advanced techniques with an intuitive, more compact system and is ideally equipped for both the ambulatory surgery center and the hospital operating room.”

The Stellaris PC offers the following benefits to surgeons and their patients:

  • It combines a sleek design, a small footprint and a wireless footpedal with Dual Linear control which allow for easier and faster set-up times and less operating room congestion.
     
  • It is the only vitreoretinal surgical system that comes with a dual light source and surgeon-selected color filters that allow for differentiated viewing designed to enhance the surgeon’s ability to see ocular tissue better under various surgical conditions.
     
  • It provides surgeons with a platform for the smallest incisions for both retinal and cataract surgeries. It is capable of 1.8 mm MICS™ phacoemulsification as well as being a complement with Bausch + Lomb's innovative TSV 25-gauge system of instruments for retinal surgery along with the 23- and standard 20-gauge instruments.
     
  • It also comes with its revolutionary Stable Chamber™ tubing system which allows for higher vacuum levels without compromising the stability of the chamber and overall safety which allows for truly small incision cataract surgery without the risk of potential surges in the eye.

Russ Finlay, global marketing director, Vitreoretinal Business, Bausch + Lomb, noted, “When we spoke with the surgeons about the type of device they prefer, they emphasized how important it was to keep this device intuitive for the surgeon. As a result, we designed the Stellaris PC for simplicity and efficiency which lets the surgeon keep his or her mind on the patient and not the system set-up. The Stellaris is an advanced, versatile and unique product that will help retinal and cataract surgeons around the world in their efforts to achieve improved patient care and clinical efficiency."

Robert Grant, president and CEO, Surgical Business, Bausch + Lomb, commented, “I am very excited that we have this innovative and proven technology to provide for our physician customers and their patients.”

The Stellaris PC replaces the Millennium® Microsurgical System.

#  #  #

About Bausch + Lomb
Bausch + Lomb is dedicated to bringing visionary ideas to eye health. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. The Bausch + Lomb name is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.

Stellaris, MICS, and Millennium are trademarks of Bausch & Lomb Incorporated.
510 (k) Pending